Teva Pharmaceutical Industries
TEVA
$13.62
Share price
2.78%
Change (1 day)
65.47%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $35.35 B
According to Teva Pharmaceutical Industries's latest financial reports the company's total liabilities are $35.35 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Teva Pharmaceutical Industries - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $35.35 B | -0.17% |
| 2022-12-31 | $35.41 B | -2.77% |
| 2021-12-31 | $36.42 B | -7.98% |
| 2020-12-31 | $39.57 B | -6.67% |
| 2019-12-31 | $42.40 B | -5.53% |
| 2018-12-31 | $44.88 B | -13.46% |
| 2017-12-31 | $51.87 B | -10.67% |
| 2016-12-31 | $58.06 B | 138.89% |
| 2015-12-31 | $24.30 B | 5.38% |
| 2014-12-31 | $23.06 B | -7.27% |
| 2013-12-31 | $24.87 B | -10.35% |
| 2012-12-31 | $27.74 B | -0.21% |
| 2011-12-31 | $27.79 B | 72.13% |
| 2010-12-31 | $16.15 B | 15.76% |
| 2009-12-31 | $13.95 B | -15.67% |
| 2008-12-31 | $16.54 B | 71.4% |
| 2007-12-31 | $9.65 B | 3.85% |
| 2006-12-31 | $9.29 B | 114.3% |
| 2005-12-31 | $4.33 B | 2.48% |
| 2004-12-31 | $4.23 B | 61.54% |
| 2003-12-31 | $2.61 B | -6.18% |
| 2002-12-31 | $2.79 B | 34.43% |
| 2001-12-31 | $2.07 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $53.19 B | 50.47% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 288.12% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | 62.96% | 🇫🇷 France |
 Merck MRK | $69.04 B | 95.29% | 🇺🇸 USA |
 AstraZeneca AZN | $61.95 B | 75.24% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $58.82 B | 66.39% | 🇬🇧 UK |
 Dr. Reddy's RDY | $1.26 B | -96.43% | 🇮🇳 India |